Related Experiment Video

Updated: May 15, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

A role for LRIG1 in the regulation of malignant glioma aggressiveness

Feng Mao1, Baofeng Wang, Qungen Xiao

  • 1Department of Neurosurgery and Sino-German Neuro-Oncology Molecular Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, P.R. China.

International Journal of Oncology
|January 23, 2013
PubMed

Insights

LRIG1, a tumor suppressor, inhibits malignant glioma growth by slowing cell division and reducing invasion. Restoring LRIG1 may offer a new therapeutic strategy for aggressive astrocytic tumors.

Area of Science:

  • Neuro-oncology
  • Molecular biology
  • Cancer research

Background:

  • Malignant astrocytic tumors (gliomas) have obscure molecular drivers.
  • LRIG1, a potential tumor suppressor, is downregulated in many cancers, including gliomas.
  • The exact role and mechanisms of LRIG1 in gliomagenesis are unclear.

Purpose of the Study:

  • To investigate the function of LRIG1 in malignant glioma.
  • To explore the molecular mechanisms by which LRIG1 affects glioma progression.
  • To assess the therapeutic potential of LRIG1 restoration in glioma.

Main Methods:

  • Overexpression of full-length LRIG1 in the U251 malignant glioma cell line.
  • In vitro assays (MTT, soft agar, transwell invasion, wound scratch) and in vivo xenografts.
  • Analysis of cell cycle regulators (cyclins), matrix metalloproteinases (MMP2, MMP9), and signaling pathways (ERK, AKT).

Main Results:

  • LRIG1 overexpression inhibited glioma cell proliferation, migration, and invasion.
  • LRIG1 delayed cell cycle progression by altering cyclin expression.
  • LRIG1 attenuated MMP2 and MMP9 production and inhibited the PI3K/AKT pathway.
  • p-ERK levels remained unchanged, while p-AKT levels were reduced.

Conclusions:

  • LRIG1 suppresses glioma aggressiveness by inhibiting proliferation, migration, and invasion.
  • LRIG1 exerts its effects partly through the PI3K/AKT signaling pathway.
  • Restoring LRIG1 expression represents a potential novel therapeutic strategy for gliomas.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...